Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.

•The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and major depressive episodes.•Depression awareness, detection, diagnostics, personalized treatment and a suitable follow-up schedule need to be integrated worldwide.•Treatment comprises antidepressants, psychosocial therapies and lifestyle changes.•Although not approved for this indication, menopausal hormone therapy may improve depressive symptoms in peri- but not in postmenopausal women.•A stronger evidence base is needed for the use of alternative and complementary therapies.